Fourth member of Oncopeptides’ Nomination Committee appointed for the 2017 AGM
Stockholm - March 22, 2017 - Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that the composition of the Nomination Committee has now been completed.At the Extraordinary General Meeting October 26, 2016 it was resolved to establish a Nomination Committee according to principles laid down and in preparation for the AGM 2017. The Committee shall consist of four members representing the three largest shareholders, together with the Chairman of the Board. At the end of 2016 the Nomination Committee consisted of Staffan Lindstrand (chairman) nominated by HealthCap VI L.P., Nina Rawal